Current Research and Scholarly Interests
I am interested not only in improving the medical care of post-op patients in the hospital, but also in improving quality of care both in the hospital as well as at the local and national health systems level. I am also interested in innovative ways in which to incorporate technology into the routine practice of medicine.

Bio
Dr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.

Current Research and Scholarly Interests
Language impairments affect up to 19% of school age children and these deficits are predictive of long-term problems affecting learning, academic achievement, and behavior. My primary research goal is to understand the neurobiological foundations of language impairments. Specifically, I am interested in how the perception and neural coding of speech impact language and other behavioral deficits in children, with a focus on children with reading disabilities and autism spectrum disorders.

Current Research and Scholarly Interests
Dr. Abrams' research is focused on the role that joint synovial tissue and inflammatory mediators have on rotator cuff pathology as well as cartilage lesions in the shoulder, knee, and hip.

Current Research and Scholarly Interests
My interest is in the care and evaluation of newborns. In particular, I have been focusing on improving the educational experience for our residents and students in the nursery regarding the examination and management of term or near-term infants.

Current Research and Scholarly Interests
As part of the Stanford Emergency Medicine International Team my work has focused on emergency medicine education and capacity development in resource limited settings, including Myanmar, India, Uganda, Nepal and others. I am currently living and working in Cambodia, providing technical advice for the USAID funded Quality Health Services Project, where our work focuses on strengthening the Cambodian emergency referral system and increasing emergency skills amongst providers.

Bio
Maya Adam MD has been teaching at Stanford University since 2009. She received her BA in Human Biology from Stanford before studying medicine at the University of British Columbia in Vancouver, Canada. Prior to her post-secondary studies, she spent 10 years as a professional ballet dancer with the State Theater of Saxony in Germany. At the Stanford School of Medicine, Adam creates online educational content for the Re-imagining Medical Education Project, led by Charles Prober MD, Senior Associate Dean for Medical Education. In the Program in Human Biology, Adam teaches courses on child health and nutrition. In 2013, Adam created the free, massive open online course Stanford Child Nutrition and Cooking, a public health education outreach effort that has reached more than 300,000 international students. She is also the founder of a non-profit organization called Just Cook for Kids. In 2014, Adam started applying the new teaching technologies being developed at Stanford to the creation of digital teaching tools designed to support the work of international community health workers. The resulting Stanford Health Outreach App is now being used by community health organizations in South Africa and Guatemala and the teaching videos associated with the app have been translated into Xhosa, Spanish and Hindi. In 2015 Adam created the online CME course Food and Medicine and the parallel open online course, Food and Health. She is the author of Food Love Family: A Practical Guide to Child Nutrition.

Bio
Steven Adelsheim, MD is a child/adolescent and adult psychiatrist who works to support community behavioral health partnerships locally, regionally, at the state level and nationally. He is the Director of the Stanford Center for Youth Mental Health and Wellbeing in the Department of Psychiatry. Dr. Adelsheim has partnered in developing statewide mental health policy and systems, including those focused on school mental health, telebehavioral health, tribal behavioral health programs, and suicide prevention. For many years Dr. Adelsheim has been developing and implementing early detection/intervention programs for young people in school-based and primary care settings, including programs for depression, anxiety, prodromal symptoms of psychosis, and first episodes of psychosis. Dr. Adelsheim is also involved in the implementation of integrated behavioral health care models in primary care settings as well as the use of media to decrease stigma surrounding mental health issues. He is currently leading the US effort to implement the headspace model of mental health early intervention for young people ages 12-25 based in Australia. Dr. Adelsheim also leads the national clinical network for early psychosis programs called PEPPNET.

Current Research and Scholarly Interests
The development and implementation of computerized, image-guided surgical tools to be used during minimally invasive brain operations. The clinical outcome of new technologies, and in particular the application of radiosurgery, for the treatment of brain tumors. The creation of new radiosurgical techniques for a wide array of brain and spine disorders.

Current Research and Scholarly Interests
I am interested in the prevention and management of infectious complication in pediatric oncology patients. I am also interested in developing a protocol for the management of low risk patients with fever and neutropenia.

Current Research and Scholarly Interests
Hematopoietic Stem cell biology-created a SCID mouse model to study engraftment of cord blood derived hematopoietic cells and use of this model to develop gene transfer technology for Fanconi anemia.Clinical research interests are to develop new protocols to reduce toxicity from high doses of chemotherapy and radiation therapy and development of a comprehensive late effects clinic for the long term follow up of transplant patients.

Current Research and Scholarly Interests
Part of the Society for Pediatric Anesthesia Information Network (SPAIN) Steering Committee, looking at shirt and long tern outcomes of various pain management techniques in children.

Current Research and Scholarly Interests
My research is focused on disorders of human feeding including the eating disorders: anorexia nervosa, bulimia nervosa, and binge eating disorder. Ongoing or recently completed studies include: A controlled trial of the implementation of interpersonal psychotherapy for eating disorders and depression on college campuses across the U.S. A multisite controlled study of two types of family therapy for the treatment of adolescent anorexia nervosa. Early prevemtion of overweight and obesity.

Current Research and Scholarly Interests
Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system

Current Research and Scholarly Interests
Our groups research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of diffusion- and perfusion-weighted MRI to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

Bio
Dr. Ronald Albucher is the Director of Counseling and Psychological Services at Vaden Health Center. His undergraduate training was at University of Pennsylvania and he attended University of Michigan for medical school and residency. Dr. Albucher subsequently joined the faculty at the University of Michigan Medical School’s Department of Psychiatry, where he specialized in Anxiety Disorders, Mental Health treatment of university residents and medical students, and also ran the Ann Arbor VA Medical Center’s Mental Health Clinic. Dr. Albucher was the Associate Training Director, University of Michigan, Department of Psychiatry for approximately 10 years. Ron has been very involved in organized psychiatry, holding numerous positions with the American Psychiatric Association, Michigan Psychiatric Society, and the Northern California Psychiatric Society.

Ron joined Stanford University in September 2008, when he became Director of Counseling and Psychological Services, and a Clinical Associate Professor of Psychiatry in the Medical School’ s Department of Psychiatry. Dr. Albucher has presented at a variety of conferences, published two books on Board Review, and has published scientific research in peer reviewed journals. He continues to serve on the review boards of several journals and publications and is working on two projects currently: eBridge to Wellness (a multisite study of online based outreach to at risk college students), and investigating the implementation of a short-term psychotherapy model in college counseling centers.

Current Research and Scholarly Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

Current Research and Scholarly Interests
Dr. Allisons clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as HER2 testing), the utility of molecular panel-based testing in breast cancer, and identifying the most appropriate management of specific pathologic diagnoses. She is also the author of Red Sunshine, a memoir about her personal experience with breast cancer, a topic which she speaks about to both patient and health care audiences.

Current Research and Scholarly Interests
I refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/

Current Research and Scholarly Interests
The overall objective of the Alvira Laboratory is to elucidate the mechanisms that promote postnatal lung development and repair, by focusing on three main scientific goals: (i) identification of the signaling pathways that direct the transition between the saccular and alveolar stages of lung development; (ii) exploration of the interplay between postnatal vascular and alveolar development; and (iii) determination of developmentally regulated pathways that mediate lung repair after injury.

Current Research and Scholarly Interests
My laboratory studies the strategies pathogens utilize to colonize and subvert the epithelial barrier. We have focused on the epithelial junctions as a target for bacterial pathogens, since the cell-cell junctions serve as both a barrier to infection and also a major control site for epithelial function. In particular, we are interested in how the gastric pathogen Helicobater pylori may cause cancer by interfering with cell signaling at the epithelial junctions. We are also studying how various bacteria cross and invade the epithelium. For example, we recently found that Listeria monocytogenes targets a specialized subset of cell-cell junctions at the tip of the intestinal villi to find its receptor for invasion. We are interested in determining whether this mode of gastrointestinal invasion of the epithelium is also used by other gastrointestinal pathogens.

Current Research and Scholarly Interests
Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.

Current Research and Scholarly Interests
Clinical Medical Research devoted to tertiary level application of treatment modalities for neurologic and functional disturbances of the genitourinary tract. Problems such as urinary incontinence, urinary retention, urinary flow dysfunction (BPH), impotence, and chronic pelvic pain syndromes are addressed. New medical devices and technology for treating these disorders are investigated

Current Research and Scholarly Interests
Our research focuses on the investigation of the brain’s innate immune response, and the role that maladaptive microglial activity plays in initiation and progression of neurological disease.

Current Research and Scholarly Interests
Our laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.

Current Research and Scholarly Interests
Professor Andriacchi's research focuses on the biomechanics of human locomotion and applications to medical devices, sports injury, osteoarthritis, the anterior cruciate ligament and low cost prosthetic limbs

Current Research and Scholarly Interests
My research efforts are focused on investigating the pharmacological and physiological interface of the autonomic nervous system with effector organs. Utilizing molecular, cellular, and electrophysiological techniques, we are examining alpha2 adrenergic receptor function in cultured sympathetic neurons. Future research aims will be directed toward understanding neurotransmitter release in general.

Current Research and Scholarly Interests
The ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders

DIABETESThe prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.

(1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.

(2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.

HEREDIATY PARAGAGLIOMA SYNDROMEThe Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.

As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families.

The first 28 years of my career were spent in clinical practice combining both DBP and primary care (the latter focused on serving CSHCN). During those years I was involved in numerous divide-bridging efforts - including programs to coordinate inpatient & outpatient medicine, connect tertiary & primary care, and promote teamwork between pediatricians, psychologists, nurse practitioners, and other community partners. I founded my own solo practice in 1989 and managed its growth to an 8-provider group over the next 25 years. Our practice was a founding member of the PPOC and I served on its board of directors for 6 years. The PPOC is one of the largest pediatric IPA’s in the country, with >200 member providers affiliated with Boston Children's Hospital. Over the years we've been involved in groundbreaking QI initiatives including those involving asthma, weight, and ADHD management; medical home; and behavioral health integration with primary care.

I’m pleased now to have an opportunity for a “second act” on the clinician-educator track here at Stanford. I hope to use my unique experience straddling primary care and sub-specialty worlds to develop programs supporting DB assessment and care inside the medical home generally, and across the Packard Children's Health Alliance primary care network in particular.

Bio
Dr Appelboom is Clinical Instructor of Neurosurgery at Stanford. Dr Appelboom is focused on advancing minimally invasive surgical techniques for diseases of the brain and spine.

Dr Appelboom is a surgeon scientist. He spent 3 years of integrated PhD research at Columbia University Medical Center to study genetic predictors of vascular fragility. Dr Appelboom has authored over 60 peer reviewed publications in international journals including Stroke, Translational Stroke Research, Current Atherosclerosis Reports, and Journal of Neurology, Neurosurgery & Psychiatry. He has also completed a master in stereotactic neurosurgery at La Sorbonne University in Paris. Dr Appelboom’s research efforts include utilization of MR guided technologies such as stereotactic radiosurgery and focused ultrasound.

Dr Appelboom is a Stanford faculty with an entrepreneurial spirit. He was selected to be a 2017 Faculty Fellow at the Byers Center for Biodesign. The program provides the most in-depth training experience in health technology innovation with a multidisciplinary experience that involve hands-on health technology projects with the help of Biodesign faculty and industry experts.

Current Research and Scholarly Interests
I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors.

Current Research and Scholarly Interests
Developmental Physiology and Sudden Infant Death Syndrome Research Laboratory closed in 2008.

Current effort, as Chair of Task Force and neonatal consult at the FDA, is to establish through consensus a culture of investigation and collaboration for all clinical neonatology practices: academic, corporate and community based to maximize the opportunity to participate in research effort needed for the regulatory approval of neonatal therapeutics to improve the outcome of critically ill infants.

Bio
Danit Ariel, MD MS, is double board certified in Internal Medicine and Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.

Dr. Ariel practices general endocrinology. She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.

Dr. Ariel also conducts research in the field of metabolism and is involved in medical student education.

Appointments with with Dr. Ariel are available on Stanford's main campus on 300 Pasteur Drive.

Current Research and Scholarly Interests
Current research interests include treatment outcome for major depression, particularly treatment refractory and chronic forms of major depression, as well as mediators and moderators of outcome; the epidemiology of chronic pain and depression; relationships between child maltreatment and adult sequelae, including psychiatric, medical and health care utilization.

Current Research and Scholarly Interests
Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

Current Research and Scholarly Interests
Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

Current Research and Scholarly Interests
The Ashley lab is focused on the application of genomics to medicine. We develop methods for the interpretation of whole genome sequencing data to improve diagnosis of genetic disease and to personalize the practice of medicine. We also use network approaches to characterize biology. The wet bench is where we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality of our favorite targets.

Current Research and Scholarly Interests
Our research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.

Current Research and Scholarly Interests
I am interested in optimizing the process of diagnosing leukemias, lymphomas and other hematolymphoid neoplasms, particularly by the use of diagnostic flow cytometry. One goal is to develop flow data analysis processes that function as interactive tools, allowing pathologists to query rich diagnostic data sets in real time.

Current Research and Scholarly Interests
As the Director of the Muslims and Mental Health Lab, Dr. Awaad is dedicated to creating an academic home for the study of mental health as it relates to the Islamic faith and Muslim populations. The lab aims to provide the intellectual resources to clinicians, researchers, trainees, educators, community and religious leaders working with or studying Muslims.

Current Research and Scholarly Interests
Virtual Reality Congenital Heart Disease experience: The Stanford Virtual Heart. Diagnosis and treatment of acute kidney injury (AKI) in children with cardiac disease, especially after surgical repair with cardiopulmonary bypass. Published our findings on prophylactic aminophylline use in children who undergo surgery with bypass; the "KID PRO-AM" (KIDney PROtection with AMinophyllline) study.